Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.
Published in NatureBiotechnology
Authors: Michael Casasanta , Nicholas Frame & Oded Ben-Joseph
Abstract:
• Exploring strategic decision-making within the prostate cancer market; a look at the intersection of innovation and opportunism
• We explore how leading companies are adapting to maintain and grow market leadership in an environment of patent expiry, technological advancement, and regulatory landscape shifts
• There has been a flurry of transactional activity in the space among medical device and pharmaceutical companies in recent years
Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.
DownloadOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?